Childhood obesity is a complex medical condition influenced by genetics, hormones, brain signaling, and environment. It is not a failure of willpower, parenting, or personal responsibility. Yet families often face confusion, stigma, and difficult decisions when a child continues to struggle with weight despite healthy efforts. In recent years, medications known as GLP-1 receptor agonists have become an important option for some children and adolescents with obesity. These treatments work by helping regulate hunger and support metabolic health. Using long-term medication in a developing child requires careful medical guidance and thoughtful family decision-making. This evidence-based, compassionate guide is written for parents and caregivers who want clear, balanced information about GLP-1 therapy in childhood obesity. It explains how childhood obesity develops in the body, how GLP-1 medications work, who may be an appropriate candidate, and what benefits and risks should be considered. The book also addresses the many aspects of treatment, including stigma, self-esteem, and the importance of shared decision-making between families and healthcare teams. Whether your family is just beginning to explore treatment options or already working with a medical provider, this book provides practical, trustworthy guidance to help families make informed choices focused on a child’s health, growth, and well-being.
Aperçu
Sélectionnez une option de livraison
COULD A GLP-1 MEDICATION HELP MY CHILD? AN EVIDENCE-BASED GUIDE FOR FAMILIES CONSIDERING MEDICATIONS FOR THE TREATMENT OF CHILDHOOD OBESITY
1 Item ajouté au panier 1 Item ajouté au ramassage